120 related articles for article (PubMed ID: 2897767)
21. Effect of serum and CTL on focal growth of human cytomegalovirus.
Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
[TBL] [Abstract][Full Text] [Related]
22. Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display.
Beghetto E; Paolis FD; Spadoni A; Del Porto P; Buffolano W; Gargano N
J Virol Methods; 2008 Jul; 151(1):7-14. PubMed ID: 18499273
[TBL] [Abstract][Full Text] [Related]
23. [Inclusion bodies of human cytomegalovirus are composed of the DNA and immediately early and early antigens of the virus].
Yan QG; Huang GS; Guo Y; Wang Z; Feng JL; Yang GR
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):262-5. PubMed ID: 15340573
[TBL] [Abstract][Full Text] [Related]
24. Human immune responses to major human cytomegalovirus glycoprotein complexes.
Liu YN; Kari B; Gehrz RC
J Virol; 1988 Mar; 62(3):1066-70. PubMed ID: 2828655
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
Bissinger AL; Oettle H; Jahn G; Neuhaus P; Sinzger C
J Med Virol; 2004 May; 73(1):45-53. PubMed ID: 15042647
[TBL] [Abstract][Full Text] [Related]
26. A 28000 molecular weight human cytomegalovirus structural polypeptide studied by means of a specific monoclonal antibody.
Re MC; Landini MP; Coppolecchia P; Furlini G; La Placa M
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2507-11. PubMed ID: 2997381
[TBL] [Abstract][Full Text] [Related]
27. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
28. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
Rahbar AR; Sundqvist VA; Wirgart BZ; Grillner L; Söderberg-Naucler C
Transfusion; 2004 Jul; 44(7):1059-66. PubMed ID: 15225248
[TBL] [Abstract][Full Text] [Related]
29. Replication of human cytomegalovirus in human retinal glial cells.
Burd EM; Pulido JS; Puro DG; O'Brien WJ
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):1957-66. PubMed ID: 8814135
[TBL] [Abstract][Full Text] [Related]
30. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus.
Alexander H; Harpprecht J; Podzuweit HG; Rautenberg P; Müller-Ruchholtz W
Hum Antibodies Hybridomas; 1994; 5(1-2):81-90. PubMed ID: 7858186
[TBL] [Abstract][Full Text] [Related]
31. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
Weber B; Braun W; Cinatl J; Doerr HW
Clin Investig; 1993 Apr; 71(4):270-6. PubMed ID: 8386033
[TBL] [Abstract][Full Text] [Related]
32. Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
Kim MN; Park CG; Hwang ES; Lim DG; Park JW; Seoh JY; Kook YH; Lee HJ; Choi SB; Cha CY
J Korean Med Sci; 1994 Dec; 9(6):476-81. PubMed ID: 7786444
[TBL] [Abstract][Full Text] [Related]
33. Analysis by immunoblotting of human cytomegalovirus antibody in sera of renal transplant recipient.
Shimokawa K; Murayama T; Ishida S; Furukawa T
J Med Virol; 1987 Apr; 21(4):339-46. PubMed ID: 3035072
[TBL] [Abstract][Full Text] [Related]
34. Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein.
Grazia Revello M; Percivalle E; Zannino M; Rossi V; Gerna G
J Virol Methods; 1991 Dec; 35(3):315-29. PubMed ID: 1667791
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary use of recombinant glycoprotein 52kd as an antigen in the diagnosis of human cytomegalovirus infection].
Wu J; Tang Z; Chen J; Gu J; Wan D; Qu S; Li H
Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):13-6. PubMed ID: 1328025
[TBL] [Abstract][Full Text] [Related]
36. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Jahn G; Plachter B
J Clin Microbiol; 1995 Jul; 33(7):1927-30. PubMed ID: 7665674
[TBL] [Abstract][Full Text] [Related]
37. Antibody responses to human cytomegalovirus-specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection.
van Zanten J; van der Giessen M; van Son WJ; The TH
J Med Virol; 1993 Jan; 39(1):80-7. PubMed ID: 8380844
[TBL] [Abstract][Full Text] [Related]
38. Immune response to guinea pig cytomegalovirus polypeptides and cross reactivity with human cytomegalovirus.
Kacica MA; Harrison CJ; Myers MG; Bernstein DI
J Med Virol; 1990 Nov; 32(3):155-9. PubMed ID: 2177780
[TBL] [Abstract][Full Text] [Related]
39. Antibody reactivity to human and vervet cytomegalovirus early antigen(s) in sera from patients with active cytomegalovirus infections and from asymptomatic donors.
Waner JL; Biano SA
J Clin Microbiol; 1979 Jan; 9(1):134-40. PubMed ID: 219017
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a 52K protein of murine cytomegalovirus and its immunological cross-reactivity with the DNA-binding protein ICP36 of human cytomegalovirus.
Pande H; Campo K; Shanley JD; Creeger ES; Artishevsky A; Gallez-Hawkins G; Zaia JA
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1421-7. PubMed ID: 1646282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
